Multi-omics Basics
Multi-omics is the core strategy of systems biology: by integrating data across molecular layers—genome, transcriptome, proteome, metabolome and epigenome—it reconstructs the complete regulatory network from gene to phenotype. Compared with
Methodology note · content is citable as-is
- More comprehensive: covers the full information flow from DNA → RNA → protein → metabolite
- More precise: cross-validation improves biomarker-discovery reliability
- Deeper mechanism: reveals how genotype shapes phenotype through multi-layer regulation
- Personalized: delivers multi-dimensional molecular portraits for precision medicine
01What Is Multi-Omics?
Multi-omics is the core strategy of systems biology: by integrating data across molecular layers—genome, transcriptome, proteome, metabolome and epigenome—it reconstructs the complete regulatory network from gene to phenotype. Compared with any single omics, multi-omics resolves biological complexity from multiple dimensions at once: the genome reveals genetic potential, the transcriptome reflects gene-expression dynamics, the proteome presents the functional executors, and the metabolome is the end-product layer closest to phenotype. Through cross-validation and integrative analysis, multi-omics not only improves the reliability of biomarker discovery but also reveals how genotype shapes phenotype through multi-layered regulation, providing comprehensive molecular evidence for precision medicine, disease-mechanism research and drug development.
Core Strengths of Multi-Omics
- More comprehensive: covers the full information flow from DNA → RNA → protein → metabolite
- More precise: cross-validation improves biomarker-discovery reliability
- Deeper mechanism: reveals how genotype shapes phenotype through multi-layer regulation
- Personalized: delivers multi-dimensional molecular portraits for precision medicine
Common Multi-Omics Combinations
- Genome + Transcriptome: resolving eQTLs and expression regulation
- Transcriptome + Proteome: assessing post-transcriptional regulation efficiency
- Proteome + Metabolome: resolving enzyme function and pathway activity
- Full-omics integration: the most comprehensive systems-biology strategy
02The Omics Layers in Detail
Genomics
Studies the complete DNA sequence of an organism and its variation. Core technologies include whole-genome sequencing (WGS), whole-exome sequencing (WES) and targeted sequencing. Detects SNPs, InDels, CNVs, SVs and other variant types—the foremost layer for understanding the genetic basis of life.
- Key technologies: Illumina NGS、PacBio HiFi、Oxford Nanopore
- Data output: 30–90 GB per sample (WGS 30×)
- Analysis: variant calling, annotation, pathogenicity classification
Transcriptomics
Quantifies the types and abundance of all RNA transcripts in cells or tissues, including mRNA, lncRNA and miRNA. Single-cell RNA-seq and spatial transcriptomics further deliver cellular resolution and spatial localization.
- Key technologies: bulk RNA-seq, scRNA-seq, spatial transcriptomics
- Data output: 5–10 GB per sample
- Analysis: differential expression, pathway enrichment, cell clustering
Proteomics
Large-scale identification and quantification of protein expression, modification and interaction. Mass spectrometry (DDA/DIA/PRM) is the core technology; 4D proteomics (ion mobility) further improves identification depth and quantification accuracy.
- Key technologies: DIA、TMT、PRM、4D-Proteomics
- Identification depth: 8,000–12,000 proteins per run
- Analysis: differential proteins, PTMs, protein-interaction networks
Metabolomics
Profiles the complete set of small-molecule metabolites (MW <1500 Da) in a biological system. As the end products of gene and protein function, metabolites directly reflect physiological and pathological states—making metabolomics the layer "closest to phenotype."
- Key technologies: LC-MS/MS、GC-MS、NMR
- Coverage: hundreds to thousands of metabolites detected
- Analysis: metabolite identification, pathway analysis, disease biomarkers
Epigenomics
Studies heritable gene-expression regulation that does not alter the DNA sequence, including DNA methylation, histone modification and chromatin accessibility—an important bridge between environment and genes.
- Key technologies: WGBS、RRBS、ChIP-seq、ATAC-seq
- Analysis: methylation levels, open-chromatin regions, TF binding sites
- Featured applications: early development, tumorigenesis, environmental-exposure studies
03The General Multi-Omics Workflow
From scientific question to biological discovery, multi-omics research follows a rigorous standardized workflow
Question
define the biological question, objectives and hypotheses
Study Design
sample-size estimation, group design, batch-effect control
Sampling
standardized collection, aliquoting, freezing and QC records
Instrument Run
data acquisition on sequencers / mass spectrometers, raw-data output
Bioinformatics
QC, alignment/database search, quantification, differential and enrichment analysis
Integration
cross-omics association, pathway integration, biological conclusions
04Technology Comparison Across Omics Layers
| Omics layer | Targets | Mainstream technologies | Data per sample | Turnaround |
|---|---|---|---|---|
| Genomics | DNA sequence & variation | WGS / WES / Targeted | 30–90 GB | 3–7 working days |
| Transcriptomics | RNA expression abundance | RNA-seq / scRNA-seq | 5–10 GB | 3–5 working days |
| Proteomics | protein expression & modification | DIA / TMT / PRM | 10–50 GB (raw data) | 5–10 working days |
| Metabolomics | small-molecule metabolites | LC-MS / GC-MS | 1–5 GB | 5–7 working days |
| Epigenomics | DNA / histone modification | WGBS / ATAC-seq | 20–60 GB | 5–10 working days |

